Stay updated on Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial

Sign up to get notified when there's something new on the Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice; the page no longer displays an administrative banner about funding status, which does not impact the study details or how a user interacts with the page.
    Difference
    0.4%
    Check dated 2025-11-17T06:19:51.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page changes appear to be cosmetic UI/layout updates to the study record; core content such as the study title, conditions, eligibility criteria, and outcomes remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T00:56:34.000Z thumbnail image
  4. Check
    49 days ago
    Change Detected
    Summary
    Update adds a government-funding status notice and NIH Clinical Center operating details with a v3.2.0 revision, while removing the old v3.1.0 tag.
    Difference
    5%
    Check dated 2025-10-05T08:03:24.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Updated the page from revision v3.0.2 to v3.1.0, signaling a new release version.
    Difference
    0.1%
    Check dated 2025-09-28T02:57:43.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2, replacing the previous revision label. A 'Back to Top' element was removed, but no other substantive content changes were detected.
    Difference
    0.3%
    Check dated 2025-09-13T17:43:41.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.3%
    Check dated 2025-09-06T15:26:38.000Z thumbnail image

Stay in the know with updates to Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial page.